Creatine monohydrate (3 to 5 grams daily) is probably the single most evidence-supported supplement for preserving lean mass on a GLP-1-driven caloric deficit, and the creatine and GLP-1 guide makes a compelling case for its inclusion
If brenipatide demonstrates a meaningful reduction in heavy drinking days in a Phase 3 registration trial, the addressable market is not a niche
Over the course of several weeks or months, you may experience a noticeable reduction in appetite and cravings
Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial
The medication provides a window of opportunity to learn portion control, make better food choices, and establish an exercise routine